3-Phosphoinositide-dependent kinase 1 (PDK1) is also a potential target since myeloid-selective knockout of PDK1 alters the phenotype of TAMs, enhances IFNγ expression in NK cells, and suppresses tumour growth in a mouse breast cancer model [64]. The gene discussed is PDK1; the disease is neoplasm.